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Summary
OBJECTIVE: Affected women and health professionals
are still often unsure about how to react to exposures to
potentially harmful agents during pregnancy. We wanted
to find out which agents worry both pregnant women and
professionals, under what circumstances the exposures
take place, how they are currently dealt with and how seri-
ous they are.
METHODS: Making use of the archives of Tox Info Suisse,
the foundation that provides poisons information in
Switzerland both for members of the general public and
for healthcare professionals, we set up an analysis of
exposures to possibly harmful agents during pregnancy.
Queries during pregnancy between 1995 and 2015 were
analysed. Demographic information, exposure and agent
characteristics as well as – in a subgroup of cases – the
corresponding treatments were considered in the present
descriptive, retrospective analysis.
RESULTS: Over the 21-year period, 2871 exposures dur-
ing pregnancy were identified. The majority of the calls
were made by members of the general public (2035,
70.9%; most often by the affected women themselves),
followed by physicians (733, 25.5%). General public
queries were mostly due to exposures connected with
household chemicals (675/2035, 33.2%); those of physi-
cians were most often due to medications (415/733,
56.6%). The majority of agent exposures occurred acci-
dentally at home, at work, outdoors or at various other
places (2297/2871, 80.0%). Less frequently, the expo-
sures were intentional and had a suicidal, abusive, crim-
inal or other character (471/2871, 16.4%). Of the 2871
calls, 905 cases with symptoms were recorded. Of the
1268 symptoms, 820 were mild (64.7%), 144 moderate
(11.3%), 24 severe (1.9%, including 12 abortions) and 280
were not further specified (22.1%). In 1867 cases (65%),
a total of 2331 measures were recommended by Tox Info
Suisse, 1961 thereof to be carried out immediately. The
two most common immediate measures were exposure in-
terruption (412/1961, 21.0%) and forwarding to another in-
stitution (345/1961, 17.6%). In 70 cases, physicians’ fol-
low-up reports could be analysed; paracetamol was the
agent most frequently involved (15 cases), followed by
mefenamic acid (9) and the household product sodium
hypochlorite (9).
CONCLUSIONS: Tox Info Suisse recorded an average of
137 cases of agent exposure during pregnancy per year,
mostly due to accidents with household products. Suicidal
intentions played a role in a considerable number of expo-
sures. Measures are needed to prevent accidental expo-
sure of pregnant women to toxic substances and to sup-
port them in this exceptional life period.
Key words: pregnancy, poisoning, intoxications, house-
hold products, medication, suicide, Switzerland, Tox Info
Suisse
Introduction
Pregnancy is an exceptional period in a woman’s life and
brings numerous physiological, psychological and social
changes for the future mother. The sudden responsibility
for the unborn child’s health can cause uncertainty, espe-
cially concerning potentially detrimental and possibly pre-
ventable factors such as exposure to harmful agents [1].
The still sparse knowledge about exogenous influences on
the health of a pregnant woman and on the development
of her unborn child can cause insecurity among health
professionals [2], employers of pregnant women and even
manufacturers of products that might be used by pregnant
women.
As early as 1909, Féré had the idea that external influences
could have an impact on the child’s intrauterine maturation
and was one of the first investigators to start experimenting
with various chemicals applied to chicken embryos to pro-
duce abnormalities [3]. Since the thalidomide scandal of
1961/62, both the research community and the general
public have become keenly aware that medications can be
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dangerous for a child’s intrauterine development. Howev-
er, it remains a challenge to ensure the safety of unborn
children, mainly because prospective clinical trials can be
performed on pregnant women only in exceptional cases.
In this context, retrospective studies on cases of accidental
and suicidal poisonings with medications, and on out-
comes after immediate treatment of acute intoxications can
provide important information concerning teratogenicity
and abortion induction [4–9]. Finally, how physicians and
pregnant women perceive the teratogenic risk of several
medications has been investigated [10, 11]. These stud-
ies focused on the use of medications during pregnancy,
whereas pregnant women are exposed to many other po-
tentially harmful agents daily, such as food products and
household chemicals.
The present work provides an overview of exposures to all
potentially harmful agents of pregnant women in Switzer-
land, as documented by Tox Info Suisse. This organisation
provides poisons information in Switzerland both for
members of the general public and for healthcare profes-
sionals. In addition to this service, Tox Info Suisse con-
tributes to clinical and evidence-based knowledge about
intoxications through systematic documentation of cases,
treatment instructions and outcomes.
Methods
Ethical statement
The data were generated from the database of Tox Info Su-
isse and handed over to the authors with patient identities
encrypted (approval by the ethics committee of the canton
of Zurich, BASEC-Nr PB 2016-00472).
Tox Info Suisse
Tox Info Suisse is a financially independent foundation,
established in 1966 and associated with the University of
Zurich since 2011. Its principal responsibility is operat-
ing a free 24-hour helpline (telephone number 145), which
covers all Switzerland, for all questions concerning poi-
soning. The information is provided by physicians, veteri-
narians, pharmacists and nurses trained in clinical toxicol-
ogy. The service is provided in three of the four official
languages in Switzerland (German, French, Italian), as
well as in English, and covers a population of about 8.5
million people. In the electronic in-house database, demo-
graphic information, agents involved in exposures, circum-
stances of exposure, route of application, and any specific
measures advised are recorded in a systematic and stan-
dardised manner. Further information such as questions
posed by the calling party, symptoms described and spe-
cific measures recommended by Tox Info Suisse are not-
ed in free-text fields. In cases of calls from health profes-
sionals, Tox Info Suisse asks for follow-up reports on the
clinical course of the exposure. This supplementary infor-
mation includes the systematic assessment of the overall
severity of the exposure and the causal correlation between
symptoms and exposure as evaluated by the trained staff of
Tox Info Suisse. Furthermore, as in the primary calls, in-
formation on symptoms, clinical course, decontamination
measures, and both specific and symptomatic therapies is
noted, both in a standardised way and in free-text fields.
Identification of cases
Appropriate cases were identified from among those
archived between 1995 and 2015 in the Tox Info Suisse
in-house database. The inclusion criterion was “exposure
during pregnancy”, and all calls addressing effects on the
mother and/or on the child were considered. It should be
noted that “agent exposure” is not synonymous with “in-
toxication”. The latter is defined as an agent exposure that
causes symptoms, whereas agent exposure per se does not
necessarily cause symptoms.
Since the criterion “exposure during pregnancy” was not
systematically recorded, the free-text field for the patient’s
medical history was screened for expressions synonymous
with or related to pregnancy in the English, German,
French and Italian languages. These included conception,
gestation, gravidity, pregnant, pregnancy, Gravida (Ger.:
pregnant woman), schwanger (Ger.: pregnant), SSW (Ger.
abbr.: week of pregnancy), SSM (Ger. abbr.: month of
pregnancy), enceinte (Fr.: pregnant), gravidité (Fr.: preg-
nancy), grossesse (Fr.: pregnancy), gravidanza (It.: preg-
nancy) and incinta (It.: pregnant). The cases identified
were extracted from the database and reviewed one by one
to eliminate those mentioning the search terms in contexts
other than pregnancy at the time of agent exposure (e.g.,
“since her pregnancy, two years ago, the patient…”).
For the evaluation of follow-up reports by health profes-
sionals, only exposures where the association between
women’s symptoms and the agent was considered proven
or likely or no symptoms occurred at all were included in
the analysis. For sake of clarity, exposures with agents in-
volved in four or fewer cases are not shown.
Primary calls
The queries made by the caller were assigned to one of
eleven predefined question categories. The symptoms were
allocated to either the mother or the child, assessed for
severity based on the Poisoning Severity Score first pre-
sented by Persson et al. [12], and assigned to the organ or
functional system afflicted. Since the description of com-
plaints was not always precise enough to assign them to
one symptom or its associated system, certain symptoms
were combined into larger symptom-groups (for example:
irritation of pharynx/larynx/trachea). Finally, headache
was assigned to the organ system “neurological”, stomach
ache to “gastrointestinal” and “irritation of pharynx/larynx/
trachea” to otorhinolaryngeal, although strictly speaking
they do not afflict only one single system.
The correlation between the patient’s account, the agent
involved and symptoms was evaluated by the specialised
staff of Tox Info Suisse with the support of their internal
database, books, publications, specialist literature,
swissmedicinfo.ch and material safety data sheets. A cor-
relation was defined as adequate if at least one symptom
fitted the possible clinical manifestation of the agent in-
volved.
Follow-up reports by health professionals
In addition to the systematically recorded parameters, in-
formation in the free text fields was translated into new
phrased parameters. These included additional symptoms
– assigned to the corresponding organ system or functional
system – the decontamination measures, and specific and
symptomatic therapy.
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Data analysis
All parameters were analysed with descriptive statistics
using the statistics program “SPSS” Version 22.0. Unless
otherwise mentioned, data are shown as number (n) and as
percentage (%).
Results
Sociodemographic characterisation
A total of 2871 cases of exposure during pregnancy were
identified. The majority of the calls were made by mem-
bers of the general public (2035/2871, 70.9%), followed
by physicians (733/2871, 25.5%) and in 103 cases (out of
2871, 3.6%), Tox Info Suisse was contacted by other par-
ties (pharmacists, veterinarians, toxicological centres, oth-
er organisations, unknown callers; fig.1). Among the calls
made by members of the general public, most were made
by the affected women themselves (1562/2035, 76.8%),
but in some cases their partners, parents, relatives, friends
and others phoned.
The latency between exposure and time of phone call was
documented in 1806 cases and was usually 24 hours or less
(1576/1806, 87.3%). In a few cases, it was less than 1 hour
(298/1806, 16.5%). In 230 cases (out of 1806, 12.7%),
more than a day had passed by the time Tox Info Su-
isse was contacted. In cases where the stage of pregnan-
cy at the time of the call was noted (1962), only 46 calls
(2.3%) were made postpartum (fig. 1); all others (1916/
1962, 97.7%) were made during pregnancy. The number of
calls decreased slightly from the first to the third trimester
(731, 637 and 548, respectively). This decrease was due to
declining queries from physicians (265, 173 and 124, re-
spectively).
Circumstances of exposure
The majority of agent exposures (2297/2871, 80.0%) oc-
curred accidentally: 1854 at home, 232 at work, 33 out-
doors and 178 in another place. Less frequently, exposures
were intentional (471/2871, 16.4%). In 103 cases, the cir-
cumstances were adverse drug reactions, iatrogenic appli-
cations or not further specified (fig. 2). Accidental expo-
sures mostly happened at home (1854/2297, 80.7%) or
at work (232/2297, 10.1%). Intentional exposures were in
more than half of all cases with suicidal intentions (254/
471, 53.9%); otherwise they had an abusive (41), criminal
(3) or other (173) character. Physicians called more often
because of intentional intoxications (331/733, 45.2%) than
did members of the general public (115/2035, 5.7%). The
frequency of accidental exposures where the trimester at
the time of the call was known (1490) remained approx-
imately constant throughout all trimesters (511, 513 and
466, respectively). Of the intentional exposures with
trimester information at the time of the call, the number
and the number of exposures with suicidal intentions (in
total 359 and 215, respectively) decreased from the first to
the third trimester (180 and 97, 105 and 76, 74 and 42).
Route of exposure
Figure 2 shows that the main route of exposure was oral
(1524/2871, 53.1%), followed by inhalation (874/2871,
30.4%), dermal (229/2871, 8.0%) and by other routes of
exposure (244/2871, 8.5%), including animal bite/sting,
intravenous, intramuscular, subcutaneous, paravenous,
sublingual, ocular, nasal, rectal, vaginal and transplacen-
tal). For intentional exposures, oral intake was by far the
most prevalent route (405/471, 86.0%), whereas for acci-
dental exposures, the oral route was closely followed by in-
halation (1054/2297, 45.9%; 846/2297, 36.8%). From the
846 accidental inhalations, 603 occurred at home and 179
in an occupational setting (71.3% and 21.2%, respective-
ly).
Agents
Leading to approximately one third of all calls, household
products were the frontrunner among agents involved
(791/2871, 27.6%), closely followed by medications (733/
2871, 25.5%). Ranking third and fourth were technical and
industrial agents (387/2871, 13.5%) and food and bever-
ages (299/2871, 10.4%), followed by agricultural and gar-
dening products, plants, poisonous animals, hygiene prod-
ucts, mushrooms, recreational drugs, veterinary drugs and
other agents (shown in figs 1 and 2). When the medication
subclass was analysed according to the Anatomic Ther-
apeutic Chemical (ATC) classification system [13], two
Figure 1: Types of agents reported by the different parties who contacted Tox Info Suisse on agent intake during pregnancy (n = 2871)
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main groups were identified: remedies for the nervous sys-
tem (265/733, 36.2%) and the genitourinary system (74/
733, 10.1%).
Members of the general public contacted Tox Info Suisse
most frequently owing to exposure to household chemicals
(675/2035, 33.2%), followed by food and beverages (281/
2035, 13.8%), technical and industrial agents (278/2035,
13.7%), and medications (274/2035, 13.5%). Physicians
called most often to check medications (415/733, 56.6%),
household products (100/733, 13.6%), and technical and
industrial agents (88/733, 12.0%). The prevalence of the
two most frequent agent groups changed according to the
trimester of pregnancy when the call took place: during the
first trimester, calls about exposures to medications were
more numerous than calls about household products (273/
731, 37.3% vs 153/731, 20.9%), whereas this changed in
the second (154/637, 24.2% vs 165/637, 25.9%) and the
third trimesters (112/548, 20.4% v. 163/548, 29.7%).
The agents involved in accidental exposures were more
heterogeneous than those in intentional exposures (fig. 2).
Household products represented a third of all accidental
exposures (762/2297, 33.2%), followed by technical and
industrial agents (373/2297, 16.2%), and medications
(283/2297, 12.3%). In contrast, three quarters of intention-
al exposures involved medications (363/471, 77.1%). Of
the two most frequently mentioned types of agents, house-
hold products were most often inhaled (367/791, 46.4%;
35 thereof in an accidental occupational setting), whereas
medications were mostly taken orally (609/733, 83.1%).
Questions posed by callers
A total of 3507 questions were asked (fig. 3). The question
posed most frequently was whether the situation was dan-
gerous in general (1377/3507, 39.3%), followed by the
question whether the situation was dangerous specifically
for the unborn child (904/3507, 25.8%) and what measures
should be taken (582/3507, 16.6%). Only a small number
of queries were about specific danger to the mother (82/
3507, 2.3%). Questions about abortion were very rare and
comparable in intentional and in accidental exposures (to-
tal 13/3507, 0.4%; 6 vs 4, respectively).
Within the calling parties “general public” and “physi-
cians”, the question posed most frequently was how dan-
gerous the situation was (1044/2426, 43.0% of all ques-
Figure 2: Intake of various types of agents during pregnancy according to intake intention and route of exposure (n = 2871).
Figure 3: Focus of questions posed to Tox Info Suisse by the different calling parties, according to intake intention (n = 3507).
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tions from the general public, and 284/968, 29.3% of all
physician-posed questions). In contrast, the second most
frequently posed question differed: members of the general
public asked 737 times if the situation was dangerous for
the unborn child (737/2426, 30.4%), whereas physicians
asked 278 times what measures should be taken (278/968,
28.7%).
During the different trimesters, the ranking of the questions
remained similar to that for the overall total, except that the
questions concerning teratogenicity were remarkably more
frequent in the first trimester than in the second or third,
or postpartum (50, 20, 6 and 4, respectively). The question
about teratogenicity was most often posed by physicians
(66/100, 66%).
After both accidental and intentional exposures, the ques-
tion about the danger of the situation was the one posed
most frequently (1161/2761, 42.0% of all questions asked
after an accident and 195/622, 31.4% of all questions asked
after intentional exposure). However, the second most fre-
quently posed question differed: after an accident, the
callers were more concerned about the danger to the un-
born child (789/2761, 28.6%) and after an intentional ex-
posure more often about what measures should be taken
(189/622, 30.4%).
Symptoms and severity
Among all 2871 calls, 905 (31.5%) cases with symptoms
and 684 (23.8%) without symptoms were recorded. No
documentation on symptoms was available for the remain-
ing 1282 calls (44.7% of the total). In 742 of the 905 cases
with documented symptoms (742/905, 82.0%), the corre-
lation between the symptoms and the known effects of the
agent was evaluated as likely.
As shown in figure 4, a total of 1268 symptoms were
recorded. The four organ systems affected the most were
the gastrointestinal with 423 symptoms (33.4%), the neu-
rological with 264 symptoms (20.8%), the otorhinolaryn-
geal with 165 symptoms (13.0%) and the dermatological
system with 139 symptoms (11.0%). Furthermore, symp-
toms related to the respiratory (89), ophthalmological (60),
cardiovascular (31), hepatic (7), metabolic (4), muscular
(3), urological (2) and blood (1) systems, as well as 55
symptoms not assignable to an organ system, were record-
ed. Gynaecological-obstetric problems were seldom re-
ported, and comprised 6 cases of vaginal bleed, 5 cases of
uterine contractions, 2 cases of threatened abortion and 12
abortions (note that threatened abortions are listed in figure
4 as pregnant women’s symptoms, classified as severe).
Around 800 symptoms were classified as mild (820/1268,
64.7%), 144 as moderate (144/1268, 11.4%), 24 as severe
(24/1268, 1.9%; including 12 abortions) and further 280
symptoms could not be specified concerning severity (280/
1268, 22.1%) (fig. 4). In all organ systems except gynaeco-
logical-obstetric (0 mild, 0 moderate, 2 severe, 11 not fur-
ther specified, 12 abortions) and muscular systems (only
2 moderate), the predominant symptom severity was mild,
followed by moderate. Severe symptoms occurred only in
the neurological, dermatological and in the gynaecologi-
cal-obstetric systems (in fig. 4 mentioned under “others”).
In 19 children, unborn or postpartum, a total of 28 symp-
toms and two premature deliveries were recorded (data not
shown). The symptoms recorded in the children were mild
in 5, moderate in 7, severe in 5 and not further specified
in 11 cases. The symptoms were: decreased intrauterine
movement and malformation (4 of each), respiratory insuf-
ficiency (3), mild somnolence, bradycardia and no appetite
(2 of each), cramps, reduced tone, symptoms of withdraw-
al, tachypnoea, metabolic acidosis, aspiration, hypother-
mia, thrombopenia, ascites, hepatosplenomegaly and hear-
ing loss (all 1 each).
Among the various types of agents to which the women
were exposed, medications were most often associated
Figure 4: Maternal symptoms after exposure to various agents during pregnancy in relation to the affected organ system, according to their
severity (n = 1268).
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with the occurrence of symptoms (fig. 4). In 733 cases
where medications were involved, 205 (205/733, 28%) pa-
tients developed symptoms. The sum of all symptoms was
287, of which 182 were mild, 32 moderate, 4 severe and
67 not further specified; moreover, 2 abortions were de-
tected. Three out of the four severe symptoms were caused
by medications for the central nervous system and one by
a medication for the respiratory system. Of the two abor-
tions, one was associated with hormonal medication and
the other with an intake of a dietary supplement.
After medications, household chemicals caused the most
frequent occurrence of symptoms (195/791, 24.7% symp-
tomatic exposures in all cases exposed to household prod-
ucts). As shown in figure 4, these exposures led to 279
symptoms, of which the majority was mild (206), followed
by moderate (25), severe (2, including an abortion) and not
further specified (46).
Measures
In 374/2871 (13.0%) of all cases, some measures had al-
ready been taken before Tox Info Suisse was contacted.
Among these cases, a total of 385 measures were taken, of
which the two most popular actions were exposure inter-
ruption (e.g., airing the room, stopping application of the
agent), which was carried out 150 times, and active de-
contamination measures (rinsing of eyes, cleaning of skin,
etc.), carried out 144 times.
In 1867/2871 (65%), a total of 2331 measures were rec-
ommended. These measures were divided into two groups:
immediate measures, which had to be taken unconditional-
ly, and conditional measures, the execution of which was
linked to a certain condition in clinical development or di-
agnostic result. The top two of the immediate measures (to-
tal 1961) were exposure interruption (412) and forwarding
to another institution (345) mostly to an embryo toxicolog-
ical centre (88). A considerable proportion of the condi-
tional measures recommended consisted of administration
of medication (119/370).
Two hundred and seventy-four of all members of the gen-
eral public (274/2035, 13.5%) took autonomous measures
before contacting Tox Info Suisse. In 1193 cases (1193/
2035, 58.6%), Tox Info Suisse recommended further mea-
sures. Of these, the three most common immediate mea-
sures were exposure interruption (365), non-pharmaceuti-
cal decontamination (212) and contacting another institu-
tion (109). The physicians took slightly fewer measures
(87/733, 11.9%), but more frequently obtained advice for
further immediate measures (599/733, 81.7%). These in-
volved contacting another institution in 218 cases, sur-
veillance measures in 164 and medicinal decontamination
measures (e.g., activated charcoal) in 10.
Follow-up reports from health professionals
The in-house database of Tox Info Suisse included 314 fol-
low-up reports from health professionals; in 265 of these,
the symptom’s relationship with the agent in question was
considered certain or likely, or no symptoms occurred at
all. A variety of agents was involved in these 265 cases. In
the present analysis, only exposures with agents involved
in at least 5 cases were considered (9 agents; 70 expo-
sures). As shown in figure 5, a total of 137 symptoms were
considered to be caused by these agents. In the majority
of the cases, medications were involved (56/70, 80.0%).
Paracetamol was the agent most often involved (15), fol-
lowed by mefenamic acid (9) and the household product
sodium hypochlorite (9). Mostly, the symptoms were mild
(122/137, 89.1%), a few were moderate (10), one was
severe and four could not be further specified. Among
the various organ systems affected, the nervous system
showed the most symptoms (46), followed by the gastroin-
testinal system (23). In total, 25 decontamination measures
were taken, of which the application of a single dose of ac-
tivated charcoal was the most frequent (10) (fig. 6). Fifteen
specific therapies were initiated, of which the administra-
tion of N-acetyl cysteine was most frequent (10). A total of
48 different symptomatic therapies were applied (fig. 6).
Discussion
Between 1995 and 2015, Tox Info Suisse recorded an an-
nual average of 137 calls due to agent exposure during
pregnancy. This suggests that agent exposure during preg-
Figure 5: Symptoms caused by the nine most frequently mentioned agents in cases with professional feedback.
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nancy is not rare. The strengths of the present study are
the high number of calls analysed and the access to data
that are otherwise not available. Still, and for various rea-
sons (lack of looking for help, contacting other institutions,
language limitations, etc.) the documented exposures are
likely to represent only part of all exposures taking place
in Switzerland. A further limitation of the present study is
that the database was not specifically designed to answer
the questions addressed. Moreover, the purpose of Tox Info
Suisse implies a high heterogeneity of cases and limits da-
ta clustering. In the case of calls by members of the gen-
eral public, some medical and technical information might
not be complete. Finally, the information on most recorded
cases reflects a brief time period.
The great majority of calls were made by members of
the general public, implying that uncertainty about how
to handle such situations is widespread in the population.
These uncertainties mostly concerned exposures to agents
such as household products, technical and industrial
agents, and food and beverages. One quarter of all calls
were made by physicians, showing that even for health
professionals this issue remains challenging [14]. They
were most frequently concerned with exposures to medica-
tions, and such exposures were most often associated with
symptomatic cases. Besides wanting to know how danger-
ous the situation was, physicians also wanted to find out
what measures should be taken to protect both mother and
unborn child in such unfamiliar and particularly challeng-
ing circumstances.
Awareness of agent teratogenicity is crucial [15] and the
malformation risk associated with agent exposure during
pregnancy is perceived as high in the general population
[10]. Accordingly, members of the general public frequent-
ly asked about the wellbeing of the unborn child, but ter-
atogenicity was even more often an issue when physicians
contacted Tox Info Suisse than when members of the gen-
eral public did. This is in line with the comparatively high
frequency of physicians’ queries in the first trimester. Both
observations can be explained by the professionals’ knowl-
edge that the risk of teratogenicity after agent exposure
is highest during the first 8 gestational weeks [16]. The
fear of long-term damage can also explain why a consid-
erable number of phone calls were made 24 hours after
the exposure – or even later – when acute symptoms are
usually waning and queries about exposures in non-preg-
nant persons seldom occur. In contrast to these fears, the
number of symptoms that occurred in children were low
compared with the number of symptoms developed by the
mothers (28 vs 1268 in 2871 primary calls; 0 vs 137 in the
70 follow-up reports from health professionals that were
analysed). Four cases of malformation were observed in
our primary calls, and none in the follow-up reports from
health professionals. The causal correlation of the report-
ed 12 abortions with the substance to which the pregnant
women had been exposed was classified as possible in two
cases. In one case, a technical/industrial product was in-
volved (glue for foam material); in the other case, a recre-
ational drug (cannabis) could have played a role.
The relatively low number of malformations and abortions
seem to suggest that the first concern when confronted
with agent exposure during pregnancy should be the moth-
er’s wellbeing. Furthermore, our finding corroborates pre-
vious studies in which, after drug overdose, no higher rate
of malformations were found [4, 7]. Schaefer et al. stat-
ed that the acute treatment of intoxications during preg-
nancy should not differ from procedures for non-pregnant
women [9]. We feel that concern about teratogenicity was
almost excessive compared with other possible – rather im-
mediate – dangers through agent exposures, such as di-
rect effects on the mother. The majority of symptoms the
mothers experienced after accidental and intentional expo-
sures were mild. Comparable observations were reported
by Sein Anand et al., who investigated a case series of self-
poisonings, in which the clinical courses were mostly mild
or moderate [17].
More than half the intentional exposures occurred with sui-
cidal intent. This finding is consistent with a previous eval-
uation of hospital admissions of pregnant women due to
self-intoxications, which showed that 68.6% were attempt-
ed suicides [18]. Earlier work further showed that attempt-
ed suicides during pregnancy do not seem to induce a high-
er prevalence of structural birth defects [4] and completed
suicides are seldom caused by medication overdose, espe-
cially as compared to deaths by violent acts [19]. We ob-
served that medications in general and, among these, med-
ications for the nervous system were the agents mainly
involved in intentional exposures, which again is in line
with previous work [20, 21]. The latter reported that the
highest incidence of suicidal attempts is within the first
trimester, which our data confirm. Generally, pregnancy is
Figure 6: Measures taken to minimise and/or treat symptoms caused by the nine most frequently mentioned agents in cases with professional
feedback.
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a protective factor against suicide [22], but it is known that
almost 80% of all suicide attempts during pregnancy are
carried out for the first time [17]. Our data clearly show
that suicide attempts during pregnancy in Switzerland – es-
pecially during early pregnancy – cannot be ignored.
Most available feedback concerned exposure to medica-
tions. This correlates with the most frequent reason for the
first calls from physicians (medications in 56.6%). Easily
accessible analgesic drugs (paracetamol, mefenamic acid,
acetylsalicylic acid) showed the highest incidence (31),
followed by benzodiazepines and Z-drugs (18; lorazepam,
bromazepam, zolpidem), which are available only on pre-
scription. The symptoms caused by these exposures were
however mostly mild. In Switzerland, 16.7% of all women
use mental-health services during the perinatal period [23],
implying that mental issues appear with high frequency in
this period and hence such medications are present in a
considerable proportion of households. As to be expected
from the types of agents involved, the decontamination
measure initiated most frequently was the application of
activated charcoal, which inhibits gastrointestinal absorp-
tion of agents [24], and the specific treatment with N-
acetyl cysteine, which is the antidote to paracetamol.
Our results on agent exposure during pregnancy have im-
plications for Tox Info Suisse, for several professional
groups and for public health. For Tox Info Suisse, the pre-
sent work means that special attention should be paid to
pregnancy, and that cooperation with institutions dedicat-
ed to issues of teratogenicity should be intensified. These
institutions include the Swiss Teratogen Information Ser-
vice (STIS), the Federal Office of Public Health (“Bunde-
samt für Gesundheit”, BAG), the Swiss Working Group for
Perinatal Pharmacology (“Schweizerische Arbeitsgemein-
schaft für Perinatale Pharmakologie, SAPP), maternity and
gynaecological hospitals and universities.
The prevalence of occupational exposure was consider-
able, and twice as high as that for other women in the same
age range contacting Tox Info Suisse (data not shown).
Since exposure can be relevant as early as during the first
trimester, protective measures established before pregnan-
cy occurs are likely to be more effective and could con-
tribute to reducing situations of insecurity. Employers, es-
pecially those from work domains involving exposure to
possibly toxic chemical agents, should invest in informa-
tion for women of reproductive age. Moreover, since cur-
rent warning notices about (toxic) household products are
not fully effective in preventing unintentional exposures,
the manufacturers concerned should re-think their warning
texts.
Physicians directly confronted with agent exposure during
pregnancy should be aware that most immediate conse-
quences will affect the mother, and only a few the unborn
child. Therefore, it is important to prioritise the treatment
of symptoms affecting the pregnant woman. At the same
time, it appears reasonable to reduce the distress caused
by fear of miscarriage and/or teratogenicity. Since stress
during pregnancy is per se associated with poor perinatal
outcomes, this would contribute to a healthier pregnancy
course [25]. Furthermore, physicians and other health pro-
fessionals involved in antenatal care should be aware that
suicide attempts during pregnancy do occur. Since a con-
siderable proportion of the suicide attempts during preg-
nancy are first time events, an especially careful evaluation
of the suicidal status of the pregnant woman is needed. Ap-
propriate counselling of women facing difficult situations
during pregnancy, including possible involvement of close
social contacts might reduce the rate of attempted suicides.
Pregnancy remains a particularly challenging period in a
women’s life. From the public health point of view, mul-
tiple efforts should be made to support and reassure preg-
nant women. Several professional groups and the society
in general should be sensitised for this need and motivated
to participate in those efforts thereby contributing to im-
prove the future health of both mothers and their offspring.
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